Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors.
about
Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors.Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.Correlation of immune phenotype with IDH mutation in diffuse glioma.The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerMyc Cooperates with Ras by Programming Inflammation and Immune Suppression.Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung.Immunohistochemistry for predictive biomarkers in non-small cell lung cancer.Programmed death-ligand 1 immunohistochemistry testing for non-small cell lung cancer in practice.Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma.Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma.
P2860
Q33813057-99FFCE7E-D625-4907-ADB9-05A76894549AQ38610336-A78F9343-6070-4084-A04E-8EF3A7057518Q38771020-4944C309-A54E-46C3-8216-954614D001B0Q41709315-A8CA3B38-1E69-4A76-8E51-5CB75E772B1EQ46758501-E82EC1E6-8390-49A8-93FD-D628378DF96AQ47117334-8733D9DC-0934-49F0-B49A-CB7D4B65EBBEQ47140225-6D3F3842-BFE3-4497-9675-52ADA3FC5782Q48190359-C3466307-1342-4B07-8908-EF1A7BB26D6FQ50636979-BA867B73-0208-4736-BDE8-8EBF0836F320Q55262931-6B3130D7-7A81-4139-9761-78C3FC48B3C4
P2860
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@en
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@nl
type
label
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@en
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@nl
prefLabel
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@en
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@nl
P2093
P2860
P1433
P1476
Scoring of PD-L1 expression in ...... h clinicopathological factors.
@en
P2093
Jun Hanaoka
Koji Teramoto
Mitsuaki Ishida
Tomoyuki Igarashi
Yataro Daigo
P2860
P304
P356
10.1136/ESMOOPEN-2016-000083
P577
2016-08-26T00:00:00Z